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Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated
glucose uptake in adipocytes
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Calpains are a family of non-lysosomal cysteine proteases.
Recent studies have identified a member of the calpain family of
proteases, calpain 10, as a putative diabetes-susceptibility gene
that may be involved in the development of type 2 diabetes.
Inhibition of calpain activity has been shown to reduce insulin-
stimulated glucose uptake in isolated rat-muscle strips and adi-
pocytes. In this report, we examine the mechanism by which
calpain affects insulin-stimulated glucose uptake in 3T3-L1 adi-
pocytes. Inhibition of calpain activity resulted in approx. a
60 % decrease in insulin-stimulated glucose uptake. Furthermore,
inhibition of calpain activity prevented the translocation of
insulin-responsive glucose transporter 4 (GLUT4) vesicles to the
plasma membrane, as demonstrated by fluorescent microscopy
of whole cells and isolated plasma membranes; it did not, how-
ever, alter the total GLUT4 protein content. While inhibition of
calpain did not affect the insulin-mediated proximal steps of the
phosphoinositide 3-kinase pathway, it did prevent the insulin-
stimulated cortical actin reorganization required for GLUT4
translocation. Specific inhibition of calpain 10 by antisense ex-
pression reduced insulin-stimulated GLUT4 translocation and
actin reorganization. Based on these findings, we propose a
role for calpain in the actin reorganization required for insulin-
stimulated GLUT4 translocation to the plasma membrane in 3T3-
L1 adipocytes. These studies identify calpain as a novel factor
involved in GLUT4 vesicle trafficking and suggest a link between
calpain activity and the development of type 2 diabetes.
Key words: adipocyte, actin reorganization, calpain, GLUT4,
3T3-L1, translocation.
INTRODUCTION
The identification of genetic factors involved in the development
of type 2 diabetes is critical for developing effective treatments.
Recent studies have identified a member of the calpain family
of proteases, calpain 10 (CAPN10), as a diabetes susceptibility
gene [1]. Although variations in the gene that encodes CAPN10
are associated with increased risk for type 2 diabetes in specific
populations, the role of calpains in the development of type 2
diabetes is not known [2–4]. However, several lines of evidence
indicate that calpains play a role in glucose homoeostasis.
First, a specific single-nucleotide polymorphism-43 (SNP-43)
within the CAPN10 gene, has been shown to be associated with
elevated fasting blood-glucose and insulin levels and decreased
CAPN10 mRNA levels in the skeletal muscle of non-diabetic
Pima Indians [5]. Secondly, inhibition of calpain activity results in
increased insulin secretion in isolated rat pancreatic islets [6], and
thirdly, inhibition of calpain activity significantly decreases
insulin-stimulated glucose uptake in isolated rat-muscle strips and
adipocytes [6].
Calpains are non-lysosomal cysteine proteases that are known
to cleave a wide array of protein substrates, including cytoskeletal
proteins, kinases, phosphatases and transcription factors [7,8].
The physiological roles of calpain have been elucidated predomi-
nately through the use of calpain inhibitors, such as N-acetyl-Leu-
Leu-Norleu-al (ALLN) and N-acetyl-Leu-Leu-Met-al. Calpains
are involved in a number of signal-transduction pathways and
have been implicated in a variety of disorders. Defects in calpain
activity have been associated with the development of cataracts,
age-related hypertension and type 2 diabetes [1,9,10]. In addition,
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our previous findings have demonstrated that calpain activity is
required for 3T3-L1 pre-adipocyte proliferation and different-
iation [11,12]. Taken together, these findings, as well as others,
suggest that calpains function to regulate adipose-tissue mass, as
well as glucose utilization [6,11,12].
Glucose uptake, which is mediated by the insulin-responsive
glucose transporter 4 (GLUT4), is the rate-limiting step in glucose
utilization in adipocytes. Previous studies have demonstrated that
insulin-stimulated GLUT4 vesicle translocation to the plasma
membrane (PM) is critical for glucose homoeostasis [13]. Ex-
pression and localization of GLUT4 are highly regulated in
insulin-responsive tissues, such as skeletal muscle and adipose
tissue. Insulin-stimulated glucose uptake requires the activation
of several signalling pathways to mediate the translocation of
GLUT4 vesicles to the PM. The binding of insulin to its receptor
activates the tyrosine kinase activity of the receptor and results
in autophosphorylation and the subsequent phosphorylation of in-
sulin receptor substrate (IRS) proteins [14]. The IRS proteins
initiate a cascade of events that results in the translocation of
GLUT4 vesicles to the PM and glucose uptake into the cell.
One of the critical targets of IRS proteins is phosphoinositide
3-kinase (PI 3-kinase), which activates downstream targets, such
as the serine/threonine protein kinase Akt/protein kinase B [15].
Recent studies have implicated the phosphorylation of Akt in
regulating GLUT4 translocation [16]. Another factor that has been
implicated in GLUT4 translocation is dynamic actin reorganiza-
tion [17–25]. Previous studies have shown that inhibition of either
actin filament breakdown or formation significantly inhibited
GLUT4 translocation and glucose uptake [26]. Thus, inhibition of
either the insulin-stimulated PI 3-kinase pathway or the pathway
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that mediates actin reorganization results in decreased GLUT4
translocation and glucose uptake. While many factors involved
in the insulin-signalling pathway have been characterized, the
precise mechanism of GLUT4 translocation is poorly understood.
The studies presented in this paper examine the role of calpain
in glucose uptake by 3T3-L1 adipocytes, a well-characterized
cell-culture model for the study of insulin-stimulated glucose
uptake. Our findings demonstrate that inhibition of calpain activity
reduced insulin-stimulated glucose uptake by preventing actin
reorganization and thus GLUT4 translocation to the PM. More
specifically, inhibition of CAPN10 protein expression decreased
insulin-stimulated GLUT4 translocation and actin reorganization.
We also found that calpain activity is not necessary for the proper




ALLN, leupeptin and pepstatin A were purchased from Sigma
Chemical Co. (St. Louis, MO, U.S.A.). The anti-CAPN10
antibody was obtained from Triple Point Biologics, Inc. (Portland,
OR, U.S.A.) and anti-GLUT4 goat polyclonal IgG was from
Santa Cruz Biotechnology Inc. (Santa Cruz, CA, U.S.A.). Anti-
insulin receptor β-subunit (IRβ) and anti-IRS-2 antibodies
were obtained from Upstate Biotechnology (Lake Placid, NY,
U.S.A.). Anti-Akt and anti-phospho-Akt antibodies were obtained
from New England Biolabs Inc. (Beverly, MA, U.S.A.). The
anti-phosphotyrosine antibody (PY20) was obtained from BD
Transduction Laboratories (Lexington, KY, U.S.A.) and the Alexa
Fluor 594 donkey anti-goat IgG was from Molecular Probes, Inc.
(Eugene, OR, U.S.A.).
Cell culture
3T3-L1 pre-adipocytes were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10 % calf serum until con-
fluent (day − 2) and maintained for an additional 2 days (until
day 0). Differentiation was induced on day 0 by the addition of
0.5 mM methylisobutylxanthine, 1 µM dexamethasone, 1 µg/ml
of insulin and 10 % fetal bovine serum (FBS) in DMEM. After
48 h (day 2), the medium was replaced with DMEM containing
1 µg/ml of insulin and 10 % FBS. After day 4, the cells were
fed every second day with 10 % FBS in DMEM. Cytoplasmic
triglyceride droplets became abundant between days 4 and 5, and
by day 10, the cells were fully differentiated [27].
Glucose-uptake assay
Glucose-uptake assays were performed on day-10 3T3-L1
adipocytes. Briefly, pre-adipocytes were cultured in 6-well plates
and induced to differentiate using the methylisobutylxanthine/
dexamethasone/insulin protocol, as described in the previous
section. Day-10 adipocytes were serum-starved for 4 h in the pre-
sence or absence of either 100 µM ALLN, 100 µM leupeptin
or 100 µM pepstatin A, as indicated. Adipocytes were either
untreated (basal) or treated with insulin (100 nM) for 10 min,
followed by the addition of [1-14C]2-deoxy-D-glucose ([14C]2-
DOG) (0.1µCi/well) (PerkinElmer/New England Nuclear,
Shelton, CT, U.S.A.) and 5 mM glucose for an additional 10 min
at 37 ◦C. Cells were then washed three times with ice-cold PBS
and solubilized in a solution containing 0.5 M NaOH and 0.1 %
(w/v) SDS. Samples were assayed for [14C]2-DOG-uptake as
disintegrations per min and normalized to the basal level of
glucose uptake, which was set at 1.
Calpain assay
Calpain activity was determined by measuring the hydrolysis
of the fluorogenic calpain substrate succinyl-leucyl-leucyl-valyl-
tyrosyl-7-amino-4-methylcoumarin (Biomol, Plymouth Meeting,
PA, U.S.A.) [28]. Day-10 3T3-L1 adipocytes were serum-starved
for 4 h and treated according to the glucose-uptake protocol, as
described above. The cells were then washed twice with ice-cold
PBS containing 1 mM Na3VO4, and lysed in a buffer containing
50 mM Hepes (pH 7.6), 150 mM NaCl, 1 % (v/v) Triton
X-100, 10 mM 2-mercaptoethanol, 0.1 mM PMSF and 10 µg/ml
leupeptin. Equal volumes of lysates were diluted in Hanks
balanced salt solution (Invitrogen/Gibco, Carlsbad, CA, U.S.A.)
and incubated at 37 ◦C. At t = 0 min, 50 µM succinyl-leucyl-
leucyl-valyl-tyrosyl-7-amino-4-methylcoumarin was added, and
fluorescence was measured for 3 min at excitation and emission
wavelengths of 380 nm and 460 nm, respectively. Protein concen-
trations were determined using the bicinchoninic acid protein
determination kit (Pierce, Rockford, IL, U.S.A). To calculate
the relative calpain activity, the rate of increase in fluorescence
was divided by the protein concentration and normalized to basal
activity, which was set at 1.
Immunofluorescence
3T3-L1 pre-adipocytes were cultured on sterilized glass coverslips
and induced to differentiate using the methylisobutylxanth-
ine/dexamethasone/insulin protocol, as described above. Day-10
adipocytes were serum-starved for 4 h and treated according
to the glucose-uptake protocol (omitting [14C]2-DOG). After
treatment, cells were fixed with 2 % buffered paraformaldehyde,
permeablized in 0.25 % (v/v) Triton X-100 (Sigma-Aldrich, St.
Louis, MO, U.S.A.) for 5 min on ice, and incubated with an
anti-GLUT4 antibody or rhodamine-labelled phalloidin. Treated
coverslips were mounted on glass slides and visualized by fluor-
escent microscopy.
Plasma lawn assay
Day-10 adipocytes were serum-starved for 4 h and treated
according to the glucose-uptake protocol (omitting [14C]2-DOG).
A plasma lawn assay was performed as described by Kanzaki
and Pessin [26]. Briefly, adipocytes were rinsed with ice-cold
PBS and incubated in 0.5 mg/ml of poly-(L-lysine) for 1 min.
Cells were then swollen in a hypotonic buffer (23 mM KCl,
10 mM Hepes, 2 mM MgCl2, 1 mM EDTA, pH 7.5) and soni-
cated in 15 ml of sonication buffer (70 mM KCl, 30 mM Hepes,
6 mM MgCl2, 3 mM EGTA, 1 mM dithiothreitol, 0.1 mM
phenylmethylsulphonyl fluoride, pH 7.5) using a probe sonicator.
Plasma membrane sheets were washed twice with sonication
buffer, incubated with an anti-GLUT4 antibody, and subjected to
fluorescent microscopy. Images from three independent experi-
ments (six random images from each treatment) were quantified
using Image-Pro Plus software (Silver Spring, MD, U.S.A.).
Subcellular fractionation
Day-10 adipocytes were serum-starved for 4 h and treated ac-
cording to the glucose-uptake protocol (omitting [14C]2-DOG).
Subcellular fractionation was performed as described by Piper
et al. [29]. Briefly, cells were collected in HES buffer [255 mM
sucrose, 20 mM Hepes (pH 7.4) and 1 mM EDTA] and homo-
genized with a Dounce homogenizer (seven strokes). The
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homogenate was centrifuged at 19 000 g for 20 min. The resulting
supernatant was centrifuged at 41 000 g for 20 min to collect high-
density microsomes. Low-density microsomes were obtained
by centrifugation of the previously obtained supernatant at
180 000 g for 75 min. The pellet obtained from the initial centri-
fugation was layered on a 1.12 M sucrose gradient and centrifuged
at 100 000 g for 60 min to obtain the PM fraction and the
mitochondrial/nuclear fraction. The PM fraction was then cen-
trifuged at 40 000 g for 20 min.
Immunoprecipitation assays and immunoblotting
Cell monolayers (on 10-cm plates) were washed once with
PBS and lysed in a buffer containing 25 mM Hepes (pH 7.4),
1 % Nonidet P-40, 100 mM NaCl, 2 % (v/v) glycerol, 5 mM
NaF, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaPPi, 1 mM PMSF,
10 mg/ml aprotinin, 5 mg/ml leupeptin and 5 mg/ml pepstatin
[26]. Lysates were gently mixed for 20 min and then centrifuged
for 20 min at 4 ◦C before determination of protein concentration
by the bicinchoninic acid method. For immunoprecipitation
assays, antibodies against either IRβ (10 µg/ml) or IRS-2 (8 µg/
ml) were added to protein lysates (600 µg); incubation occurred
for 1 h at 4 ◦C. Agarose beads (Protein A/G PLUS-Agarose beads,
Santa Cruz Biotechnology Inc.) were mixed with the immuno-
precipitates on a rocker for 1 h at 4 ◦C. Immunoprecipitates
were recovered by centrifugation at 2500 g and washed three
times with ice-cold lysis buffer. Immunoprecipitated proteins
were dissolved in 2 × Laemmli buffer, heated for 5 min at 95 ◦C,
subjected to SDS/PAGE, and transferred to Immobilon-P
membranes (Millipore, Billerica, MT, U.S.A.). Membranes were
incubated with the indicated primary antibodies and visualized
by enhanced chemiluminescence. Protein bands were quanti-
fied by densitometry using NIH Image (v1.29) software.
Stable transfection
A tetracycline-regulated (TET-ON) expression system (Invitro-
gen, Carlsbad, CA, U.S.A.) was used to express a full-length
antisense CAPN10 cDNA in 3T3-L1 adipocytes. Pre-confluent
pre-adipocytes were co-transfected with a pBI-TET-antisense
CAPN10 vector and a pRevTRE expression vector. Clonal cell
lines were selected for G418 resistance. Cells harbouring the
transgene were induced to differentiate for 6 days as described
above. Cells were then incubated in the presence or absence of
doxycycline for 72 h and subjected to the immunofluorescence
protocol and probed with either an anti-GLUT4 antibody or
rhodamine-labelled phalloidin.
RESULTS
Inhibition of calpain activity reduces insulin-stimulated
glucose uptake in 3T3-L1 adipocytes
Previous studies have shown that inhibition of calpain activity
results in a decrease in insulin-stimulated glucose uptake in rat
adipocytes [6]. Since there are no CAPN10-specific chemical
inhibitors available at present, Sreenan et al. [6] used a variety of
protease inhibitors to implicate calpain activity in glucose homo-
eostasis. To investigate further the role of calpain in glucose
uptake, we chose the 3T3-L1 cell line model, which has been
used extensively to delineate the mechanism of insulin-stimulated
glucose uptake in adipocytes. In order to determine whether
3T3-L1 adipocytes are similar to primary rat adipocytes in
their requirement for calpain activity during insulin-stimulated
glucose uptake, we serum-starved day-10 3T3-L1 adipocytes for
Figure 1 ALLN treatment results in decreased insulin-stimulated glucose
uptake and calpain activity
Day-10 3T3-L1 adipocytes were serum-starved and incubated in the absence or presence of ALLN
(100 µM) and subsequently treated with or without insulin (100 nM). (A) 3T3-L1 adipocytes
were assayed for [14C]2-DOG uptake under the basal condition or after insulin stimulation in
the absence and presence of ALLN, 100 µM leupeptin (Leu) or 100 µM pepstatin A (Pep). The
results are the means +− S.D. of three independent experiments. *Significantly different from
insulin-treated level (P < 0.01). (B) 3T3-L1 adipocytes were assayed for relative calpain activity
as described in the Materials and Methods section. The results are the means +− S.E.M. of ten
assays. *P < 0.001). (C) Lysates were collected from cells with different treatments as indicated
and CAPN10 protein levels were assayed by Western-blot analysis using a specific anti-
CAPN10 antibody.
4 h in the absence or presence of the calpain inhibitor ALLN
(100 µM) and performed radiolabelled [1-14C]2-DOG uptake
assays as described in the Materials and Methods section. As
shown in Figure 1(A), [14C]2-DOG uptake was increased by
approx. 8-fold in insulin-stimulated 3T3-L1 adipocytes compared
with unstimulated adipocytes. In 3T3-L1 adipocytes that were
stimulated with insulin in the presence of ALLN, [14C]2-DOG
uptake was decreased by approx. 60% compared with adipocytes
stimulated with insulin alone (Figure 1A). Since calpain is a
cysteine protease, we examined the effect of leupeptin, a cell-
permeant cysteine-protease inhibitor [30], on insulin-stimulated
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glucose uptake. In 3T3-L1 adipocytes treated with insulin plus
leupeptin (100 µM), [14C]2-DOG uptake was reduced by approx.
25% compared with the level in adipocytes stimulated with
insulin alone (Figure 1A). In contrast, the presence of the cell-
permeant aspartic-protease inhibitor pepstatin A (100 µM) [31]
had no significant effect on insulin-stimulated [14C]2-DOG uptake
(Figure 1A). The addition of protease inhibitors had no effect on
glucose uptake in unstimulated adipocytes (results not shown).
To verify that calpain activity was inhibited by ALLN during
insulin-stimulated glucose uptake, calpain activity was assayed in
adipocytes immediately after insulin-stimulated glucose uptake
by using a spectrofluorimetric assay (Figure 1B) [28]. As shown in
Figure 1(B), ALLN treatment inhibited insulin-stimulated calpain
activity by approx. 70%, which correlates with the inhibitory
effect of ALLN on insulin-stimulated glucose uptake (60%)
[Figures 1(A) and 1(B)]. Since CAPN10 has been implicated
specifically in the development of type 2 diabetes, it was of interest
to determine whether the decrease in calpain activity was due to
lower levels of CAPN10 expression. As shown in Figure 1(C),
the levels of CAPN10 protein were unaffected by either insulin or
insulin-plus-ALLN, compared with the basal level. These results
demonstrate that 3T3-L1 adipocytes are similar to primary rat
adipocytes in their requirement for calpain activity during insulin-
stimulated glucose uptake [6].
Calpain is required for GLUT4 vesicle translocation during
insulin-stimulated glucose uptake in adipocytes
A critical event in insulin-stimulated glucose uptake is the trans-
location of insulin-responsive GLUT4 vesicles to the PM. Since
inhibition of calpain activity decreased glucose uptake signifi-
cantly, it was of interest to determine whether calpain plays a role
in insulin-stimulated GLUT4 translocation. Immunofluorescent
studies were conducted to determine the effect of calpain inhi-
bition on intracellular localization of GLUT4 vesicles prior to
and during insulin-stimulated glucose uptake. Day-10 3T3-L1
adipocytes were either untreated (basal), treated with insulin or
treated with insulin plus ALLN, as described in the Materials
and Methods section. Immunofluorescent microscopy revealed
that GLUT4 vesicles were localized primarily to the perinuclear
region under the basal condition (Figure 2A, panel a). However,
upon insulin stimulation, there was a marked increase in GLUT4
translocation to the PM, as exhibited by the increase in fluorescent
staining at the cell membrane (Figure 2A, panel b). In contrast,
adipocytes treated with insulin plus ALLN showed a decreased
level of GLUT4 translocation to the PM compared with insulin-
stimulated adipocytes (Figure 2A, panel c).
In addition to the immunofluorescent studies, we conducted
plasma lawn assays to confirm quantitatively [32–34] that calpain
is required for GLUT4 translocation to the PM during insulin-
stimulated glucose uptake in the absence or presence of ALLN.
Under the basal condition, only a low level of GLUT4 staining
was detectable in PM sheets (Figure 2A, panel d). Upon insulin
stimulation, GLUT4 localization to the PM sheets increased by
approx. 3-fold (Figure 2A, panel e). These results are consistent
with previous studies that examined GLUT4 translocation to the
PM in response to insulin stimulation [26]. In contrast, insulin
stimulation in the presence of ALLN resulted in only a 1.4-fold
increase in the level of GLUT4 protein present at the PM. (Fig-
ure 2A, compare panel e with panel f). To demonstrate further
that calpain activity is required for insulin-stimulated GLUT4
translocation, we conducted subcellular fractionation analysis
(Figure 2B). Under the basal condition, a low level of GLUT4
protein was detected in the PM fraction. Upon insulin stimulation,
GLUT4 levels in the PM fraction increased by approx. 2.5-fold,
Figure 2 Insulin-stimulated GLUT4 translocation is inhibited by ALLN
treatment
Day-10 3T3-L1 adipocytes were treated according to the glucose-uptake protocol as
described in the Materials and Methods section, and GLUT4 protein was visualized by either
immunofluorescence or subcellular fractionation followed by Western-blot analysis using an
anti-GLUT4 antibody. (A) GLUT4 localization was assayed in whole cells (panels a–c) as well
as in PM sheets (panels d–f) under the basal condition or after stimulation with insulin in the
absence and presence of ALLN. Quantification of GLUT4 was determined using Image-Pro Plus
software. The results are representative images from three independent experiments. (B) Cell
homogenates were subjected to subcellular fractionation, and PM- and low-density microsome
(LDM)-fractions were obtained and subjected to SDS/PAGE as described in the Materials and
Methods section. GLUT4 protein levels were assayed by Western-blot analysis using an anti-
GLUT4 antibody. Quantification of GLUT4 was determined using NIH Image (v1.29) software.
Results are representative of three independent experiments.
whereas insulin stimulation in the presence of ALLN resulted in a
45% decrease in the levels of GLUT4 protein in the PM fraction.
These findings are consistent with the results obtained from the
PM lawn analysis. We also determined whether the decrease in
GLUT4 protein at the PM was due to a decrease in total GLUT4
protein levels in the cell. ALLN treatment did not affect the total
GLUT4 protein level, as determined by Western-blot analysis
using an anti-GLUT4 antibody (results not shown).
Calpain is not required for the expression or insulin-mediated
phosphorylation of critical signalling molecules involved
in GLUT4 translocation
Activation of the insulin receptor stimulates several different
signalling pathways that act co-ordinately to translocate GLUT4-
containing vesicles to the PM. In order to determine whether
calpain affects proximal events of the insulin-signalling pathway,
we examined critical signalling molecules of the insulin-induced
PI 3-kinase pathway. Since calpain is a protease capable of
cleaving a variety of proteins, and thus capable of affecting
their activities, the protein levels and phosphorylation status of
critical signalling molecules involved in insulin signalling during
glucose uptake were examined. Inhibition of calpain activity by
ALLN did not affect the protein levels of IRβ (Figure 3A), the
proximal signalling molecule IRS-2 (Figure 3A) or Akt (Fig-
ure 3B). Since the activities of many of the signalling molecules in
the insulin-signalling pathway are regulated by phosphorylation,
we investigated whether calpain activity is required for the
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Figure 3 ALLN does not alter the expression or phosphorylation pattern of
critical proteins involved in insulin-stimulated GLUT4 translocation
Day-10 3T3-L1 adipocytes were treated according to the glucose-uptake protocol in the absence
and presence of ALLN (100 µM) as described in the Materials and Methods section. (A) IRβ and
IRS-2 were immunoprecipitated (IP) from cell lysates, analysed by SDS/PAGE, and then immuno-
blotted (IB) with anti-IRβ or anti-IRS-2 antibodies, as indicated. The membranes were stripped
and reprobed with an anti-phosphotyrosine antibody (PY20). For IRS-1, tyrosine-phosphorylated
proteins were immunoprecipitated with PY20 and then blotted with anti-IRS-1 antibodies. (B)
Cell lysates were subjected to SDS/PAGE and then immunoblotted using specific antibodies that
recognized either Akt or phosphorylated Akt at Thr308 (pAkt/Thr308) or Ser473 (pAkt/Ser473).
The results are representative of three independent experiments.
insulin-mediated phosphorylation of these proteins. Inhibition of
calpain by ALLN treatment for 4 h (a time period that inhibited
insulin-stimulated glucose uptake) did not alter the insulin-
stimulated autophosphorylation of immunoprecipitated IRβ, or
the phosphorylation status of IRS-1 or IRS-2 (Figure 3A). We
also examined the phosphorylation status of the distal signalling
molecule Akt. Inhibition of calpain by ALLN did not alter the
insulin-stimulated phosphorylation of Akt at either Thr308 or Ser473
in 3T3-L1 adipocytes (Figure 3B). Although the phosphorylation
patterns of three critical signalling molecules were unaffected
by calpain inhibition, our findings do not exclude the possibility
that calpain might alter a critical step that is downstream of Akt,
but upstream of vesicle translocation or other insulin-stimulated
pathways.
Inhibition of calpain activity blocks insulin-induced
actin-filament reorganization
Actin reorganization has been implicated in GLUT4 vesicle
trafficking [17,19,21–23,35,36]. In adipocytes, filamentous actin
is localized to the cell cortex. Previous studies have shown that
disruption of cortical actin reorganization by either latrunculin
Figure 4 Inhibition of calpain activity alters cortical actin reorganization
(A) Day-10 3T3-L1 adipocytes were treated according to the glucose-uptake protocol as
described in the Materials and Methods section, and actin filaments were visualized by
rhodamine-labelled phalloidin immunofluorescence. Actin-filament localization and integrity
was assayed in whole cells under the basal condition (panel a and d), after stimulation with
insulin (panel b and e) or in the presence of insulin and ALLN (panel c and f). Results
are representative images from three independent experiments. (B) Total protein lysates were
collected from cells with different treatments, as indicated, and subjected to SDS/PAGE. Total
actin protein levels were assayed by Western-blot analysis using an actin-specific antibody.
B (an actin-monomer-sequestering agent) or jasplakinolide (an
agent that stabilizes actin filaments) inhibited insulin-stimulated
GLUT4 translocation to the PM and subsequent glucose uptake
[26]. Since calpains have been implicated in cytoskeletal reorgan-
ization during cell migration and cell adhesion [28,37–42],
we examined the effect of decreased calpain activity on actin
reorganization during insulin-stimulated glucose uptake. Adipo-
cytes were grown on coverslips, serum-starved for 4 h in the
absence or presence of ALLN and then subjected to the glucose-
uptake protocol as described in the Materials and Methods section.
The presence of actin filaments was assayed using rhodamine-
labelled phalloidin and immunofluorescence. As shown in Fig-
ure 4(A), unstimulated adipocytes have a diffuse actin-staining
pattern (Figure 4A, panels a and d). Upon insulin-stimulation,
cortical actin is reorganized and increased filamentous actin
staining is detected adjacent to the cortical region and the peri-
nuclear region of the cell (Figure 4A, panels b and e). In
the presence of insulin plus ALLN, there is significantly less
filamentous actin staining at the cortex and the perinuclear region
when compared with insulin-stimulated cells (Figure 4A, panels c
and f). In order to determine whether the decrease in filamentous
actin staining in the presence of ALLN was due to decreased
levels of total actin protein, we performed Western-blot analysis
using an anti-actin antibody (Figure 4B). Similar levels of total
actin protein were detected in the absence or presence of ALLN.
These findings suggest that inhibition of calpain activity blocked
actin-filament formation.
Inhibition of CAPN10 decreases insulin-stimulated GLUT4
translocation and actin reorganization
While previous studies that investigated the role of calpain in glu-
cose uptake have utilized various calpain inhibitors, the specific
role of CAPN10 has not been examined. In order to investigate
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Figure 5 Inhibition of CAPN10 decreases insulin-stimulated GLUT4 translocation and actin reorganization
Day-6 3T3-L1 cells that were stably transfected with a CAPN10 antisense expression vector were incubated in the presence or absence of doxycycline (DOX) for various times. (A) Total protein
lysates were collected from cells at the various time points, as indicated, and subjected to SDS/PAGE. Total CAPN10 protein levels were assayed by Western-blot analysis using a CAPN10-specific
antibody. Day-6 3T3-L1 adipocytes harbouring the transgene were treated for 72 h in the presence ( + DOX) or absence ( − DOX) of DOX and then subjected to the glucose-uptake protocol as
described in the Materials and Methods section in the absence and presence of 100 µM ALLN (B). The results are the means +− S.D. of three independent experiments. *Significantly different from
insulin-treated level, P < 0.01. (C) GLUT4 protein was visualized by immunofluorescence using a GLUT4-specific antibody and (D) actin filaments were visualized by immunofluorescence using
rhodamine-labelled phalloidin. The results are representative of three independent experiments.
the role of CAPN10 in glucose uptake, we generated 3T3-L1
cell lines that were stably transfected with a TET-ON CAPN10
antisense expression vector. A representative cell line harbouring
the CAPN10 antisense expression vector was induced to differ-
entiate for 6 days and then incubated in the presence of doxy-
cycline for various times to determine the time required to
reduce CAPN10 expression. As shown in Figure 5(A), there
was minimal CAPN10 expression 72 h after addition of doxy-
cycline to the culture medium. Based on this finding, we con-
ducted our experiments 72 h after doxycycline treatment. To
determine whether CAPN10 plays a role in insulin-stimulated
glucose uptake, we stimulated 3T3-L1 adipocytes harbouring the
transgene with insulin in the presence or absence of doxycycline
and then performed a glucose-uptake assay (Figure 5B). Inhibition
of CAPN10 expression (by doxycycline treatment) decreased
insulin-stimulated glucose uptake by approx. 50% compared
with untreated adipocytes. The presence of doxycycline had no
effect on basal glucose uptake (results not shown). Furthermore,
addition of ALLN to doxycycline-treated cells had no further
reduction on insulin-stimulated [14C]2-DOG uptake compared
with doxycycline-treated cells. To determine whether CAPN10
mediates GLUT4 translocation, 3T3-L1 adipocytes harbouring
the transgene were stimulated with insulin, fixed and then
probed with an anti-GLUT4 antibody (Figure 5C). Inhibition
of CAPN10 expression (by doxycycline treatment) significantly
decreased insulin-stimulated GLUT4 translocation to the PM
when compared with CAPN10-expressing adipocytes (not treated
with doxycycline) (Figure 5C). Inhibition of CAPN10 had no
effect on GLUT4 translocation under the basal condition. To
determine whether CAPN10 inhibited GLUT4 translocation by
disrupting actin reorganization, we stimulated transfected cells
with insulin and probed with rhodamine-labelled phalloidin to
localize filamentous actin. As shown in Figure 5(D), inhibition
of CAPN10 expression (by doxycycline treatment) decreased
cortical actin staining when compared with CAPN10-expressing
adipocytes (not treated with doxycycline). These studies suggest
that CAPN10 plays a specific role in GLUT4 trafficking via actin
reorganization.
c© 2003 Biochemical Society
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DISCUSSION
Previous studies have identified CAPN10 as a putative type 2
diabetes susceptibility gene [1]. SNP-43 in CAPN10 was shown
to be associated with type 2 diabetes in a population of Mexican–
Americans in Starr County, TX, U.S.A. [1]. Further studies have
shown a similar association between genetic variations within the
CAPN10 gene and the development of type 2 diabetes in other
populations [2–5]. Studies in rodents have shown that inhibition
of calpain activity increased insulin secretion in isolated rat
pancreatic islets and decreased glucose uptake in isolated rat-
muscle strips and adipocytes [6]. While the effect of inhibiting
calpain activity resulted in the primary characteristics of insulin
resistance, it is unclear how calpain functions to alter these
parameters at the cellular level.
Our findings show that inhibition of calpain activity in 3T3-L1
adipocytes reduced insulin-stimulated GLUT4 translocation to
the PM significantly by disrupting actin filament reorganization
(Figures 2, 4 and 5). We also demonstrated that this inhibition
of GLUT4 translocation was not mediated by the PI 3-kinase-
dependent pathway because inhibition of calpain activity did
not prevent the activation of critical signalling proteins in this
pathway (Figure 3). These findings suggest that calpain facilitates
GLUT4 translocation by disrupting actin reorganization in a PI
3-kinase-independent manner and furthermore, supports the idea
that insulin-induced actin reorganization is not mediated by a PI
3-kinase-dependent pathway. Our findings are highly significant
in light of the growing number of studies that implicate a role for
actin reorganization in insulin-stimulated GLUT4 translocation
[18,26,43].
Studies using the actin depolymerizing agent latrunculin B
resulted in decreased insulin-stimulated actin reorganization,
GLUT4 translocation and glucose uptake [26]. These studies
demonstrate that actin polymerization is necessary for GLUT4
translocation. Similarly, our findings show that in the presence
of calpain inhibitors, there were decreases in insulin-induced
actin filament formation and GLUT4 translocation (Figure 4).
Furthermore, specific inhibition of CAPN10 decreased insulin-
stimulated GLUT4 translocation and actin reorganization. It is
not surprising that inhibition of calpain activity resulted in the
disruption of the insulin-induced actin reorganization because
calpains have been shown to be involved in actin reorganization
during cell migration and focal-adhesion formation [28,37–
42]. Studies using calpain-deficient mouse embryonic fibroblasts
revealed that these cells were unable to form focal adhesions and
further demonstrated the requirement for calpain in the formation
of stress fibres [38]. Our results are in agreement with these studies
in that inhibition of calpain prevented actin filament formation
during insulin-stimulated glucose uptake.
While inhibition of calpain activity blocked GLUT4 trans-
location, we were unable to detect an increase in calpain activity
upon insulin stimulation (Figure 1B). One possible explanation for
this finding is that insulin mediates the translocation of an active
CAPN10 to its site of action. Previous studies have indicated
a relationship between membrane localization of calpain and
its activation [44]. Studies are underway to determine the role
of insulin on the cellular localization of CAPN10. Alternatively,
insulin may cause the translocation of a substrate to calpain or
it may mediate a conformational change in a putative substrate
making it a target for calpain. Studies are also in progress to
investigate these possibilities.
In summary, our studies show a role for calpain activity in
insulin-stimulated glucose uptake in 3T3-L1 adipocytes. Further-
more, they demonstrate that calpain facilitates insulin-induced
GLUT4 translocation to the PM via actin reorganization, but
has no affect on insulin-induced signal transduction along the
PI 3-kinase pathway. This study establishes a role for calpain
activity in the insulin-induced actin reorganization and GLUT4
vesicle trafficking required for glucose uptake. Determining the
mechanism by which calpain activity promotes GLUT4 trans-
location may provide a cellular basis for impaired insulin
sensitivity in individuals with SNP-43. The identification of a
calpain-specific target involved in actin reorganization would
not only advance our knowledge of the mechanisms underlying
insulin resistance, but also provide a possible target for pharmaco-
logical intervention.
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